EGFR and neoplasm: Its mechanism of action is as follows: it irreversibly binds to the ATP binding site of EGFR/HER1, HER2, and HER4 to prevent the formation of homo/heterodimers between the HER family, inhibit autophosphorylation, and block downstream signal transmission, thereby inhibiting tumor growth [9–11].